Navigation Links
Genomic Health Announces Third Quarter 2012 Financial Results and Business Progress
Date:11/7/2012

REDWOOD CITY, Calif., Nov. 7, 2012 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today reported financial results and business progress for the quarter ended September 30, 2012.

Total revenue increased to $58.6 million in the third quarter of 2012, compared with $52.1 million in the third quarter of 2011, an increase of 13 percent.  Product revenue was $58.4 million in the third quarter of 2012, compared with $51.7 million for the same period in 2011, an increase of 13 percent.

Net income was $3.7 million in the third quarter of 2012, compared with net income of $3.2 million in the third quarter of 2011. 

Basic and diluted net income per share applicable to common stockholders was $0.12 and $0.11, respectively in the third quarter of 2012, compared with basic and diluted net income per share of $0.11 and $0.10, respectively, for the same period in 2011.

"In the third quarter, we delivered strong net income and a 13 percent increase in year-over-year product revenue, led by significant international growth reflecting the diversification of our business and continued progress in capturing an important global opportunity," said Kim Popovits, Chairman of the Board, Chief Executive Officer and President of Genomic Health. "Further, with the announcement of positive prostate cancer validation study results, we are now positioned to leverage our proven commercial infrastructure in addressing a third major cancer, and one of the greatest needs in medicine, by making the Oncotype® DX prostate cancer test available in the first half of 2013."

Total operating expenses for the third quarter of 2012 were $54.9 million, including cost of product revenues of $9.0 million, compared with total operating expenses for the comparable
'/>"/>

SOURCE Genomic Health, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Empire Genomics Chooses Funakoshi as Japan Distributor
2. Genomic Health to Announce First Quarter 2012 Financial Results and Host Conference Call on Wednesday, May 2, 2012
3. Telik Announces the Publication of Two Reports in the Journal Of Hematology & Oncology Describing the Results of a Clinical Study of Telintra® in Combination With Revlimid® and a Genomic Study Designed to Identify Genes That Predict Response to Teli
4. Rubicon Genomics Launches ThruPLEX™ Family of Sample Preparation Products for Next Generation Sequencing Applications
5. Gentris Corporation Launches New Pharmacogenomics Services
6. Life Technologies Signs Collaborative Agreement with Structural Genomics Consortium to Develop First Antibody Master Set for Epigenetic Studies
7. Life Technologies Acquires Pinpoint Genomics and CLIA-Approved Lung Cancer Test
8. Elsevier Launches New Open Access Journal: Applied and Translational Genomics
9. Genomic Health to Announce Second Quarter 2012 Financial Results and Host Conference Call on Wednesday, August 8, 2012
10. Genomic Health to Present at the Canaccord Genuity Growth Conference
11. Frost & Sullivan Recognizes Rosetta Genomics for Its Strategic Excellence and Strong Contribution to Next-Generation Diagnostics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... May 4, 2015  Neurocrine Biosciences, Inc. (NASDAQ: ... has joined the company as Vice President, Medical ... welcome Dr. Bill Aurora to the Neurocrine ... Kevin Gorman , President and Chief Executive Officer of ... exchange and outreach coupled with his extensive network and ...
(Date:5/4/2015)... May 4, 2015  Amgen (NASDAQ: AMGN ) will ... 8 a.m. ET on Thursday, May 7, 2015, at the ... Hooper , executive vice president of Global Commercial Operations at ... presentation can be accessed from the Events Calendar on Amgen,s ... webcast will also be available on Amgen,s website for 90 ...
(Date:5/4/2015)... , May 4, 2015 DePuy Synthes CMF* ... Repair, the first commercially available biosynthesized dural replacement derived ... is a part of the DePuy Synthes Companies of ... tissue membrane that covers and protects the brain and ... to allow surgeons to access the brain. A dural ...
Breaking Medicine Technology:Neurocrine Biosciences, Inc. Announces Appointment of Dr. Bill Aurora as Vice President, Medical Affairs 2Neurocrine Biosciences, Inc. Announces Appointment of Dr. Bill Aurora as Vice President, Medical Affairs 3Amgen To Present At The Deutsche Bank 40th Annual Healthcare Conference 2DePuy Synthes CMF Launches First Biosynthesized Cellulose-Based Dural Replacement For Neurosurgery 2DePuy Synthes CMF Launches First Biosynthesized Cellulose-Based Dural Replacement For Neurosurgery 3
... YORK, Jan. 10, 2011 Resolvyx Pharmaceuticals ( Resolvyx ... ), a successor firm to Celtic Pharma, announced today ... which Celtic Therapeutics has acquired and licensed worldwide rights ... treatment of dry eye syndrome and other ophthalmic conditions. ...
... 2011 Astellas Pharma Inc. (TSE: 4503) ... to conduct, in conjunction with executive management, a review of ... Prosidion was acquired as part of Astellas, acquisition of OSI ... two drug candidates in development for diabetes and obesity, as ...
Cached Medicine Technology:Resolvyx Pharmaceuticals and Celtic Therapeutics Enter Final Agreement in Ophthalmology 2Resolvyx Pharmaceuticals and Celtic Therapeutics Enter Final Agreement in Ophthalmology 3Resolvyx Pharmaceuticals and Celtic Therapeutics Enter Final Agreement in Ophthalmology 4Astellas to Review Strategic Business Alternatives for Prosidion Subsidiary 2Astellas to Review Strategic Business Alternatives for Prosidion Subsidiary 3
(Date:5/4/2015)... NY (PRWEB) May 04, 2015 ... insurance programs, announces the expansion of coverage for its ... a leading provider of industry-tailored insurance and proactive risk ... & Company, we are dedicated to providing our customers ... meet their many evolving needs. We are excited to ...
(Date:5/4/2015)... TROY Healthcare Solutions is proud to be a ... (RUG) Conference in Baltimore, MD from May 11 – ... provides an opportunity for clients to gather to network, ... In addition to sponsoring the event, TROY Healthcare Solutions ... Conference. Attendees can stop by the TROY booth and ...
(Date:5/4/2015)... May 04, 2015 Baptist Medical ... Stroke Association’s Get With The Guidelines®-Stroke Gold Plus ... Honor Roll. The award recognizes the hospital’s commitment ... the most appropriate treatment according to nationally recognized, ... , To receive the Gold Plus Quality Achievement ...
(Date:5/4/2015)... May 04, 2015 Now in its ... clinical leaders who have made outstanding contributions to the ... serve, both in acute and post-acute care settings. The ... Post-Acute Provider of the Year, Advanced Practice Clinician of ... Provider of the Year. Recipients are selected by IPC’s ...
(Date:5/4/2015)... May 04, 2015 Los Angeles ... offering a more comfortable and attractive alternative for patients ... choice for those who have lost teeth. Unfortunately, they ... insecure or slip at the worst possible moment and ... talks. They can also painfully pinch or rub gums, ...
Breaking Medicine News(10 mins):Health News:Insurance Leader McNeil & Company Expands Coverage for Emergency Services Insurance Program (ESIP), Launches Enhancements to Property and Casualty Insurance Package 2Health News:Insurance Leader McNeil & Company Expands Coverage for Emergency Services Insurance Program (ESIP), Launches Enhancements to Property and Casualty Insurance Package 3Health News:TROY Healthcare to Exhibit at the Cerner North Atlantic Regional User Group Conference 2Health News:TROY Healthcare to Exhibit at the Cerner North Atlantic Regional User Group Conference 3Health News:Baptist Medical Center Jacksonville Receives Top Honor for Stroke Care 2Health News:Baptist Medical Center Jacksonville Receives Top Honor for Stroke Care 3Health News:Baptist Medical Center Jacksonville Receives Top Honor for Stroke Care 4Health News:IPC Healthcare Announces Clinicians of the Year 2Health News:IPC Healthcare Announces Clinicians of the Year 3Health News:Los Angeles Dental Implants Doctor, Kevin Sands DDS, Now Offers a More Comfortable and Aesthetically-Pleasing Solution to Denture-Wearers 2
... , , WAYNE, Pa., July ... documentation software, workflow tools, consulting and staffing services has announced ... Marketing and Communications. Reporting directly to founder and CEO ... marketing initiatives that blend the strong brand of Precyse,s services ...
... , BATESVILLE, Ind., July 29 Hillenbrand, Inc. (NYSE: ... the market opens Wednesday, Aug. 12, 2009. The full text of ... site at www.HillenbrandInc.com . , , ... with investors and financial analysts the same day at 8 a.m. ...
... , CARLSBAD, Calif., July ... announced today that Cardiac Science Corporation has purchased a ... Group. Cardiac Science develops, manufactures, and markets ... and Holter systems, cardiac rehabilitation telemetry, and data management ...
... , , DARIEN, Conn., July 29 ... The Switch , a sparkling 100% juice, is expanding its availability ... Amazon.com, The Switch has added key retailers Tops, ... months. And the list of eager retailers keeps growing with Wegmans, ...
... , , CARMEL, Ind., ... announced that Christopher J. Foote has been promoted to vice president, ... in 1999 and served previously as senior managing actuary for asset-liability ... and shared actuarial services. , , ...
... , SAN DIEGO, July 29 ... solutions that can reach over 3.5 billion mobile phones globally, today announced ... industry leaders. , , Key Facts: , ... the 7-member advisory board is to provide Globaltel Media,s executive management team ...
Cached Medicine News:Health News:Precyse Solutions Taps Former Siemens Executive to Lead New Marketing Organization 2Health News:Hillenbrand Announces Third-Quarter Earnings Release Date and Conference Call 2Health News:Patriot Scientific Corporation Announces Cardiac Science Corporation's Purchase of a Moore Microprocessor Patent(TM) Portfolio License 2Health News:People Across the Country are Making The Switch! 2Health News:Globaltel Media Appoints Leading Healthcare Industry Veterans to Advisory Board 2Health News:Globaltel Media Appoints Leading Healthcare Industry Veterans to Advisory Board 3
The DePuy ACE 8.0mm Cannulated Cancellous Screw incorporates TiMAX to provide superior strength, fatigue resistance and a lower modulus of elasticity when compared to similar stainless steel devices....
Biomet® Arthrodesis Nail indications include: , Failed external fixation , Aseptic failed total knee arthroplasty , Periarticular fractures where repair is not possible , Limb salvage in tumor...
True hemostasis management is achieved with the Hepcon HMS PLUS Hemostasis Management System from Medtronic. This multi-purpose, intuitive system easily performs in-vitro diagnostic procedures....
An Innovative New System to Help You Meet the Challenges of Anterior Spine Surgery...
Medicine Products: